Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
135 DURYEA RD, MELVILLE, NY
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
8 Oct 2026

Henry Schein, Inc. reported A director or senior management change or compensation event

Henry Schein, Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

22 Sep 2026

Henry Schein, Inc. reported A material agreement

Henry Schein, Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.

6 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Henry Schein, Inc..

4 Aug 2026

Henry Schein, Inc. filed Form 10-Q

Henry Schein, Inc. submitted Form 10-Q to the SEC for the period ending Jun 27, 2026.

4 Aug 2026

Henry Schein, Inc. reported Operating or financial results

Henry Schein, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis
Cash and equivalents (USD)$88.12M
Total assets (USD)$11.38B
Total liabilities (USD)$6.66B
Shareholders' equity (USD)$3.16B
Long-term debt (USD)$1.05B
Debt due within a year (USD)$17.13M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
QuarterRevenue (USD)Operating incomeNet incomeDiluted EPS (USD)Filed
Q2 2026$3.46B$171.00M$94.00M$0.8210-Q · 4 Aug 2026
Q1 2026$3.37B$182.00M$107.00M$0.9210-Q · 5 May 2026
Q4 2025$3.44B$163.00M$122.00MUnavailable10-K · 24 Feb 2026
Q3 2025$3.34B$164.00M$101.00M$0.8410-Q · 4 Nov 2025
Q2 2025$3.24B$151.00M$86.00M$0.7010-Q · 5 Aug 2025
Q1 2025$3.17B$175.00M$110.00M$0.8810-Q · 5 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy
Target: $98.13
16.5% upside potential
📈
Strong Buy
Unavailable
👍
Buy
9
⏸️
Hold
6
📉
Sell
1
16 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 64.00–112.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
8
Sep 2026
Albertini Andrea
CEO, Global Dist. & Tech.
Tax withholding
$88.86 per share
603 shares
SEC Form 4
8
Sep 2026
Albertini Andrea
CEO, Global Dist. & Tech.
Disposition to the company
Unavailable per share
3,984 shares
SEC Form 4
12
Jun 2026
DANIEL WILLIAM K
Director
Grant or award
Unavailable per share
2,215 shares
SEC Form 4
26
May 2026
BERGMAN STANLEY M
Gift
Unavailable per share
50 shares
SEC Form 4
21
May 2026
BERGMAN STANLEY M
Director
Gift
Unavailable per share
50 shares
SEC Form 4
19
May 2026
BERGMAN STANLEY M
Director
Gift
Unavailable per share
1,040 shares
SEC Form 4
11
May 2026
DANIEL WILLIAM K
Director
Open-market purchase
$69.19 per share
10,000 shares
SEC Form 4
19
Mar 2026
Popeck Thomas C
CEO, Henry Schein Products
Open-market sale
$72.79 per share
1,355 shares
SEC Form 4
16
Mar 2026
South Ronald N.
SVP & Chief Financial Officer
Tax withholding
$74.61 per share
5,216 shares
SEC Form 4

Top Shareholders

Kohlberg Kravis Roberts & Co. L.P.
15,652,032 shares
0% change
6/30/2026
Vanguard Group Inc
11,588,199 shares
-3.438% change
12/31/2025
Fmr Llc
7,553,901 shares
32.012% change
6/30/2026
Blackrock, Inc.
7,024,663 shares
0.024% change
6/30/2026
Artisan Partners Limited Partnership
6,467,467 shares
-1.606% change
6/30/2026
Vanguard Capital Management Llc
6,346,669 shares
-1.191% change
6/30/2026
Jpmorgan Chase & Co
4,342,929 shares
-4.813% change
6/30/2026
State Street Corp
4,305,276 shares
-1.683% change
6/30/2026
Vanguard Portfolio Management Llc
4,133,442 shares
-1.466% change
6/30/2026
American Century Companies Inc
3,457,175 shares
-3.817% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 16 hours ago